Anastrozole

• Post Date:

  Mar 27,2013

• Expiry Date:

  Sep 23,2013

• Detailed Description:

  Cas No. :120511-73-1 Chemical name: α,α,α',α'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1,3- benzenediacetonitrile
  
  2.Molecular formula: C17H19N5
  
  Molecular weight: 293.37
  
  CAS NO.: 120511-73-11
  
  3.Quality standard:USP32
  
  Appearance: white crystalline powder
  
  Content: ≥ 99.5%
  
  
  
  General introduction:Anastrozole is a drug used to treat breast cancer after surgery and for metastases in post-menopausal women. Anastrozole is an aromatase inhibitor, which means that it interrupts a critical step in the body's synthesis of estrogen. Some breast cancer cells require estrogen to grow, and eliminating estrogen suppresses their growth. Annual sales approx $2.2bn. The first patent expired in June 2010. Although this patent was originally set to expire in December 2009, the manufacturer was given an extension for performing
  

• CAS Registry Number:

  120511-73-1

• Synonyms:

  ;Tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-benzenediacetionitrile;ICI-D-1033;Arimidex;1-[3,5-DI-(1-METHYL-1-CYANO)-ETHYL]-BENZYL-1,2,4-TRIAZOLE;ANASTRAZOLE;tetramethyl-5-(1h-1,2,4-triazol-1ylmethyl) 1,3-benzenediacetionitrile;ZD-1033;1,3-benzenediacetonitrile,alpha,alpha,alpha',alpha'-tetramethyl-5-(1h-1,2,4-triazol-1-ylmethyl)-;Anastrozol;Anatrozole;ZD-1033, ICI-D-1033, Arimidex;2-[3-(2-Cyano-2-propyl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methylpropiononitrile;1,3-benzenediacetonitrile, alpha,alpha,alpha',alpha'-tetramethyl- 5-(1h-1,2,4-triazol-1-ylmethyl)- zd;1,3-Benzenediacetonitrile,a,a,a',a'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl);2,2'-[5-(1H-1,2,4-triazol-1-ylmethyl)benzene-1,3-diyl]bis(2-methylpropanenitrile);

• Molecular Formula:

  C₁₇H₁₉N₅

• Molecular Weight:

  293.37

• Molecular Structure:

  

• Company:

  Hubei Yuancheng Tech. Development Co.,Ltd.     [ China ]        

• Contact:

  meng

• Tel:

  +86-027-68886470

• Fax:

• Email:

  ycchem01@yccreate.com